Request Discount

Botulinum Toxin Market (Type - Botulinum Toxin Type A, and Botulinum Toxin Type B; Application - Cosmetic Applications, and Non-cosmetic Applications; End User - Hospitals, Clinics, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2027

  • Published : July, 2021

  • Rep Id : HC08690

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on the botulinum toxin market provides an in-depth analysis of segments and sub-segments in the global as well as regional botulinum toxin market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional botulinum toxin market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global botulinum toxin market. According to the report, the global botulinum toxin market is projected to grow at a CAGR of 7% over the forecast period of 2021-2027.

 

Botulinum Toxin Market


Market Insight

The botulinum toxin market was valued at nearly USD 3450 million in 2021 and is expected to reach over USD 7510 million in 2027, growing with a CAGR of around 7% over the forecast period. Botulinum toxin is a potent neurotoxin that constrains the release of acetylcholine at the neuromuscular junction. Injection of small quantities of botulinum toxin into particular overactive muscles causes localized muscle relaxation that smooths the overlying skin and lessens wrinkles. Furthermore, botulinum toxin effects take about two weeks to fully develop and last three to four months. Dynamic wrinkles, seen during muscle retrenchment, yield more dramatic results than static wrinkles, which are visible at rest. Botulinum toxin is contraindicated in persons with keloidal scarring, neuromuscular disorders (e.g., myasthenia gravis), allergies to constituents of botulinum toxin products, and body dysmorphic disorder. Temporary blepharoptosis and eyebrow ptosis are rare difficulties that are technique-dependent; incidence declines as injector skill improves.

 

The availability of minimally invasive surgeries by highly qualified aesthetic surgeons and the rising quality of care improved professional services have contributed to the growth of procedural volume. As stated by the recent data of the American Society of Plastic Surgeons (ASPS), in 2018 among the 15.9 million cosmetic minimally-invasive procedures performed in the United States, Botulinum Toxin Type A tops the list with 7.44 million processes. Moreover, technological advancements, the introduction of cost-effective aesthetic products, the aging population, and the increasing incidence of aesthetic problems, such as crow’s foot and lateral canthal lines are also enhancing the growth of the botulinum toxin market worldwide. On the other hand, the side effects of available products, lack of reimbursement policies supporting cosmetic procedures, and the high cost of the products may restrain the adoption rate of botulinum toxin during the projection period.

 

The North American region is expected to dominate the global botulinum toxin market owing to the high disposable income and supportive government regulations that have significantly influenced the growth of the botulinum toxin market in the region. Furthermore, the availability of a variety of aesthetic procedures for enhancing the external appearance is pushing the demand for botulinum toxin in the region. Moreover, the Asia Pacific region is expected to grow with the fastest CAGR in the botulinum toxin over the forecast period. The aging demographics and increasing disposable income resulting in higher demand for anti-aging products are the factors boosting regional growth.

 

Segment Covered

The report on the global botulinum toxin market covers segments such as type, application, and end user. On the basis of type, the sub-markets include botulinum toxin type a, and botulinum toxin type b. On the basis of application, the sub-markets include cosmetic applications, and non-cosmetic applications. On the basis of end user, the sub-markets include hospitals, clinics, and others.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Merz Pharma, Allergan Inc., Galderma, Evolus, Inc., Revance Therapeutics, Inc., HUGEL, Inc., Ipsen Pharma, US WorldMeds, LLC, Medytox Inc., and Lanzhou Institute of Biological Products Co. Ltd..

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the botulinum toxin market. Moreover, the study highlights current market trends and provides forecast from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount